Critical Outcome Technologies Completes Private Placement With a Successful U.S. Life Science Investor
Critical Outcome Technologies Set to Form JV with Portage Biotech Inc. for Clinical Development of COTI-2
AMENDED FROM SOURCE - Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement
